logo
Select company
Select metric
$ -3.49EBITDA per Share
VS
Market
7
Sector
19
Industry
24
History
20
$ 11.1Close
$ 7.4 - $ 16.01 52-Week Range
Ticker Information

Ticker

KALV

Company Name

KALVISTA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KALVISTA PHARMACEUTICALS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KALV - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -186.69M$ -3.49153.5M
3/31/2025$ -172.96M$ -3.48149.65M
12/31/2024$ -167.88M$ -3.19152.64M
9/30/2024$ -155.51M$ -3.33146.7M
6/30/2024$ -140.94M$ -3.05146.23M
3/31/2024$ -125.84M$ -3.42136.79M
12/31/2023$ -107.49M$ -3.1134.72M
9/30/2023$ -99.77M$ -2.89134.57M
6/30/2023$ -94.36M$ -2.74134.41M
3/31/2023$ -92.11M$ -3.3127.89M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KALVISTA PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -2.06.
  • Over the past 5 years, KALVISTA PHARMACEUTICALS INC's average EBITDAPS has been $ -2.99.
  • The median EBITDAPS for KALVISTA PHARMACEUTICALS INC during this period was $ -3.14
  • KALVISTA PHARMACEUTICALS INC reached its highest EBITDAPS over the past 5 years at $ -2.06.
  • The lowest EBITDAPS recorded by KALVISTA PHARMACEUTICALS INC in the same timeframe $ -3.7

KALVISTA PHARMACEUTICALS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
INBX : INHIBRX BIOSCIENCES INC $ -9.91PROK : PROKIDNEY CORP $ -0.5NWBO : NORTHWEST BIOTHERAPEUTICS INC $ -0.05ATAI : ATAI LIFE SCIENCES NV $ -0.59SEPN : SEPTERNA INC $ -1.91OTLK : OUTLOOK THERAPEUTICS INC $ -1.17RNAC : CARTESIAN THERAPEUTICS INC $ -1.22PLUR : PLURI INC $ -3.34CLSD : CLEARSIDE BIOMEDICAL INC $ -5.14IGC : IGC PHARMA INC $ -0.07

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for KALVISTA PHARMACEUTICALS INC is calculated as follows: EBITDA [ $ -36.96M ] / (Shares WA [ 17.91M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -2.06 ]

KALV - EBITDA per Share, Last 5 years

$ -3.7

Minimum

Sep 30, 2022

$ -2.06

Maximum

Sep 30, 2020

$ -2.99

Average

$ -3.14

Median

EBITDAPS Benchmark Analysis

The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26